Naphak Modhiran to Adult
This is a "connection" page, showing publications Naphak Modhiran has written about Adult.
Connection Strength
0.008
-
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 10; 21(10):1383-1394.
Score: 0.004
-
Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat Commun. 2021 04 01; 12(1):2037.
Score: 0.004